Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease

Area of Science:

• Genetics
• Immunology
• Endocrinology

Background:

• Graves' disease susceptibility involves genetic factors beyond the HLA region.
• Interferon-gamma (IFN-gamma), a key cytokine in thyroid autoimmunity, is implicated in Graves' disease pathogenesis.

Purpose of the Study:

• To investigate the association between a dinucleotide (CA) repeat polymorphism in the IFN-gamma gene and Graves' disease.
• To determine if specific IFN-gamma alleles are more prevalent in patients with Graves' disease, particularly those with endocrine ophthalmopathy or specific HLA markers.

Main Methods:

• Polymerase chain reaction (PCR) and polyacrylamide gel electrophoresis were used to analyze the IFN-gamma gene's first intron polymorphism.
• Two hundred two Caucasian Graves' disease patients and 214 Caucasian controls were genotyped for eight IFN-gamma alleles.

Main Results:

• The IFN-gamma*5 allele was significantly more frequent (12.9% vs. 6.8%) and IFN-gamma*2 was significantly less frequent (2.5% vs. 9.8%) in Graves' disease patients compared to controls.
• IFN-gamma*3 and IFN-gamma*5 alleles were more frequent in patients positive for HLA DQA1*0501 and in patients with endocrine ophthalmopathy compared to controls.
• A significant association was observed between IFN-gamma microsatellite polymorphism and Graves' disease, but these markers were present in only a small proportion of patients.

Conclusions:

• The studied IFN-gamma microsatellite polymorphism shows a significant association with Graves' disease susceptibility.
• These specific polymorphisms likely play a minor role in the overall genetic predisposition to Graves' disease.
• Further research may elucidate the complex genetic architecture of Graves' disease.